Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001339426 | SCV001533167 | uncertain significance | Early myoclonic encephalopathy | 2021-08-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035898 | SCV003587360 | uncertain significance | not specified | 2021-12-03 | criteria provided, single submitter | clinical testing | The c.1703A>G (p.D568G) alteration is located in exon 8 (coding exon 8) of the JMJD1C gene. This alteration results from a A to G substitution at nucleotide position 1703, causing the aspartic acid (D) at amino acid position 568 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |